Home / Research library
Reader library
Research by relationship.
Choose a category, understand where you are, then move through evidence—not through a wall of links.
59 primers · 1086 research articles · 1086 families · download the whole library (.md)
Category 01
Peptide primers
Begin with the object before following its relationships.
Peptide primerBDNF-P21: P021, a four-amino-acid fragment that raises BDNF and works when eatenEvidence record and relationship map.Peptide primerARA-290 (cibinetide): a fragment of erythropoietin that acts on nerves, not on bloodThe definitive ARA-290 (cibinetide) reference: the innate-repair-receptor mechanism, randomized human evidence of actual nerve regeneration, the 4mg/day dosing and half-life paradoPeptide primerTirzepatide: a dual GIP and GLP-1 receptor agonistEvidence record and relationship map.Peptide primerRetatrutide: the third receptor, and what the evidence now establishesOne molecule switching on GLP-1, GIP and glucagon receptors at once. Why adding glucagon to a weight-loss drug is not a mistake, the largest weight and blood-sugar effects measuredPeptide primerKisspeptin: The Receptor Break That Revealed How Puberty StartsEvidence record and relationship map.Peptide primerSelank: one 62-patient trial against a benzodiazepine, and 40 people countedEvidence record and relationship map.Peptide primerSemax: a Russian stroke drug sold as a focus spray, and what its numbers actually showEvidence record and relationship map.Peptide primerThe Wolverine stack plus ARA-290 for a degenerating disc and sciatica: the evidence at every linkEvidence record and relationship map.Peptide primerThe Wolverine stack: BPC-157 and TB-500, the evidence, the dosing arithmetic and the eight-week costEvidence record and relationship map.Peptide primerGHK-Cu: the copper tripeptide's human evidence, copper risk, and dosing arithmeticEvidence record and relationship map.Peptide primerKPV: Evidence, Stability, Dosing and the FDA RecordEvidence record and relationship map.Peptide primerThymosin Alpha-1: Approvals, Trial Record, Dosing and What It Does Not TreatEvidence record and relationship map.Peptide primerBPC-157 for a herniated disc: what the evidence reaches, and what it does notEvidence record and relationship map.Peptide primerTB-500 (Thymosin Beta-4)The definitive TB-500 / thymosin beta-4 reference: why 'TB-500' usually isn't the trialed molecule, the one positive human indication (dry eye) vs the unproven rest, real dosing/rePeptide primerDSIP (Delta Sleep-Inducing Peptide): the replication record and dosingEvidence record and relationship map.Peptide primerBPC-157: Body Protection CompoundThe definitive BPC-157 reference: the angiogenesis+FAK mechanism, the full animal record, the three human studies, real dosing/routes/reconstitution, the 2026 FDA PCAC fight, the cPeptide primerThymosin Alpha-1 × MetforminEvidence record and relationship map.Peptide primertb 500 nsaidsEvidence record and relationship map.Peptide primertb 500 metforminEvidence record and relationship map.Peptide primertb 500 herniated discEvidence record and relationship map.Peptide primertb 500 glp1 agonistsEvidence record and relationship map.Peptide primerTB-500 × Frozen shoulderEvidence record and relationship map.Peptide primersemax statinsEvidence record and relationship map.Peptide primersemax metforminEvidence record and relationship map.Peptide primerSemax × GLP-1 agonists (class)Evidence record and relationship map.Peptide primersemax benzo withdrawalEvidence record and relationship map.Peptide primersemax adderall amphetamineEvidence record and relationship map.Peptide primerselank statin brain fogEvidence record and relationship map.Peptide primerselank metforminEvidence record and relationship map.Peptide primerSelank × GLP-1 agonists (class)Evidence record and relationship map.Peptide primerselank benzodiazepinesEvidence record and relationship map.Peptide primerselank benzo withdrawalEvidence record and relationship map.Peptide primerselank adderall amphetamineEvidence record and relationship map.Peptide primerPT-141 × MetforminEvidence record and relationship map.Peptide primerPT-141: Brain-Level ArousalEvidence record and relationship map.Peptide primerKPV × MetforminEvidence record and relationship map.Peptide primerkpv glp1 agonistsEvidence record and relationship map.Peptide primerGHK-Cu × MetforminEvidence record and relationship map.Peptide primerdsip statin brain fogEvidence record and relationship map.Peptide primerdsip metforminEvidence record and relationship map.Peptide primerDSIP × GLP-1 agonists (class)Evidence record and relationship map.Peptide primerdsip benzo withdrawalEvidence record and relationship map.Peptide primerdsip adderall amphetamineEvidence record and relationship map.Peptide primerbpc 157 statinsEvidence record and relationship map.Peptide primerbpc 157 plantar fasciitisEvidence record and relationship map.Peptide primerbpc 157 ozempic faceEvidence record and relationship map.Peptide primerbpc 157 metforminEvidence record and relationship map.Peptide primerbpc 157 glp1 muscle lossEvidence record and relationship map.Peptide primerbpc 157 glp1 agonistsEvidence record and relationship map.Peptide primerbpc 157 frozen shoulderEvidence record and relationship map.Peptide primerbpc 157 degenerative discEvidence record and relationship map.Peptide primerara 290 trigeminal neuralgiaEvidence record and relationship map.Peptide primerara 290 statin brain fogEvidence record and relationship map.Peptide primerara 290 postherpetic neuralgiaEvidence record and relationship map.Peptide primerara 290 metforminEvidence record and relationship map.Peptide primerARA-290 × GLP-1 agonists (class)Evidence record and relationship map.Peptide primerara 290 chemo neuropathyEvidence record and relationship map.Peptide primerara 290 benzo withdrawalEvidence record and relationship map.Peptide primerARA-290 × Stimulant-driven insomniaEvidence record and relationship map.
Category 02
Research families
Expand one family at a time. Every article keeps its context.